Literature DB >> 27191703

Transcription Factor Drug Targets.

Kostas A Papavassiliou1, Athanasios G Papavassiliou2.   

Abstract

Transcription factors represent the point of convergence of multiple signaling pathways within eukaryotic cells. Deregulated transcription factors contribute to the pathogenesis of a plethora of human diseases, ranging from diabetes, inflammatory disorders and cardiovascular disease to many cancers, and thus these proteins hold great therapeutic potential. Direct modulation of transcription factor function by small molecules is no longer regarded a Sisyphean task, as recent work in drug discovery has revealed that transcription factors are amenable to drug inhibition. Here in we summarize, recent advances regarding the significance of transcription factors in human diseases and we discuss emerging pharmacological strategies to modulate transcription factor function. J. Cell. Biochem. 117: 2693-2696, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  DEREGULATION; HUMAN DISEASE; MUTATION; THERAPEUTIC TARGET; TRANSCRIPTION FACTORS

Mesh:

Substances:

Year:  2016        PMID: 27191703     DOI: 10.1002/jcb.25605

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  25 in total

1.  Integrative analysis of differential circular RNA and long non-coding RNA profiles and associated competing endogenous RNA networks in esophageal squamous cell carcinoma.

Authors:  Jiang-Feng Shen; Jin-Feng Ge; Shi-Ying Zheng; Dong Jiang
Journal:  Funct Integr Genomics       Date:  2021-01-07       Impact factor: 3.410

2.  Identification of PDL1-Related Biomarkers to Select Lung Adenocarcinoma Patients for PD1/PDL1 Inhibitors.

Authors:  Yanping Wu; Lianjun Lin; Xinmin Liu
Journal:  Dis Markers       Date:  2020-06-09       Impact factor: 3.434

Review 3.  Polyploidy in development and tumor models in Drosophila.

Authors:  Caique Almeida Machado Costa; Xian-Feng Wang; Calder Ellsworth; Wu-Min Deng
Journal:  Semin Cancer Biol       Date:  2021-09-22       Impact factor: 17.012

4.  Analysis of Time Series Gene Expression and DNA Methylation Reveals the Molecular Features of Myocardial Infarction Progression.

Authors:  Yuru Han; Baoyu Duan; Jing Wu; Yanjun Zheng; Yinchen Gu; Xiaomeng Cai; Changlian Lu; Xubo Wu; Yanfei Li; Xuefeng Gu
Journal:  Front Cardiovasc Med       Date:  2022-06-24

Review 5.  Current strategies and progress for targeting the "undruggable" transcription factors.

Authors:  Jing-Jing Zhuang; Qian Liu; Da-Lei Wu; Lu Tie
Journal:  Acta Pharmacol Sin       Date:  2022-02-07       Impact factor: 7.169

Review 6.  Cyclic AMP in dendritic cells: A novel potential target for disease-modifying agents in asthma and other allergic disorders.

Authors:  Amy M Chinn; Paul A Insel
Journal:  Br J Pharmacol       Date:  2020-06-21       Impact factor: 8.739

Review 7.  Replication Stress, Genomic Instability, and Replication Timing: A Complex Relationship.

Authors:  Lina-Marie Briu; Chrystelle Maric; Jean-Charles Cadoret
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

Review 8.  The Impact of Anthocyanins and Iridoids on Transcription Factors Crucial for Lipid and Cholesterol Homeostasis.

Authors:  Maciej Danielewski; Agnieszka Matuszewska; Adam Szeląg; Tomasz Sozański
Journal:  Int J Mol Sci       Date:  2021-06-04       Impact factor: 5.923

Review 9.  Target acquired: transcriptional regulators as drug targets for protozoan parasites.

Authors:  H A Walters; L A Temesvari
Journal:  Int J Parasitol       Date:  2021-03-13       Impact factor: 4.330

10.  REGGAE: a novel approach for the identification of key transcriptional regulators.

Authors:  Tim Kehl; Lara Schneider; Kathrin Kattler; Daniel Stöckel; Jenny Wegert; Nico Gerstner; Nicole Ludwig; Ute Distler; Markus Schick; Ulrich Keller; Stefan Tenzer; Manfred Gessler; Jörn Walter; Andreas Keller; Norbert Graf; Eckart Meese; Hans-Peter Lenhof
Journal:  Bioinformatics       Date:  2018-10-15       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.